Tocqueville Asset Management L.P. Eli Lilly & CO Transaction History

Tocqueville Asset Management L.P.

$6.27 Billion
Q3 2024

A detailed history of Tocqueville Asset Management L.P. transactions in Eli Lilly & CO stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 20,048 shares of LLY stock, worth $16 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

20,048

Previous 20,173 0.62%

Holding current value

$16 Million

Previous $18.3 Million 2.75%

% of portfolio

0.28%

Previous 0.3%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$772.14 - $960.02 $96,517 - $120,002	-125 Reduced 0.62%	20,048 $17.8 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $313,143 - $392,705	-432 Reduced 2.1%	20,173 $18.3 Million
Q1 2024 May 09, 2024	BUY	$592.2 - $792.28 $2.49 Million - $3.34 Million	4,213 Added 25.7%	20,605 $16 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $4.43 Million - $5.22 Million	8,429 Added 105.85%	16,392 $9.56 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $74,768 - $103,079	-172 Reduced 2.11%	7,963 $4.28 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $39,633 - $52,994	113 Added 1.41%	8,135 $3.82 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $85,733 - $100,690	276 Added 3.56%	8,022 $2.75 Million
Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $17,363 - $20,232	54 Added 0.7%	7,746 $2.83 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $2,075 - $2,365	-7 Reduced 0.09%	7,692 $2.49 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $728,042 - $854,829	-2,612 Reduced 25.33%	7,699 $2.5 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $23,469 - $29,166	-100 Reduced 0.96%	10,311 $2.95 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $2,248 - $2,790	10 Added 0.1%	10,411 $2.88 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $1,551 - $1,908	7 Added 0.07%	10,401 $2.4 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $137,759 - $178,191	-763 Reduced 6.84%	10,394 $2.39 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $295,118 - $382,045	-1,796 Reduced 13.87%	11,157 $2.08 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $34,963 - $46,264	-268 Reduced 2.03%	12,953 $2.19 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $57,172 - $66,129	-391 Reduced 2.87%	13,221 $1.96 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $283,753 - $341,494	-2,080 Reduced 13.26%	13,612 $2.24 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $77,263 - $95,630	649 Added 4.31%	15,692 $2.18 Million
Q4 2019 Jan 14, 2020	BUY	$106.92 - $132.43 $395,390 - $489,726	3,698 Added 32.6%	15,043 $1.98 Million
Q3 2019 Oct 31, 2019	SELL	$106.79 - $116.16 $632,837 - $688,364	-5,926 Reduced 34.31%	11,345 $1.27 Million
Q2 2019 Jul 31, 2019	SELL	$110.79 - $129.32 $7,422 - $8,664	-67 Reduced 0.39%	17,271 $1.91 Million
Q1 2019 Apr 30, 2019	SELL	$111.31 - $131.02 $14,470 - $17,032	-130 Reduced 0.74%	17,338 $2.25 Million
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $37,700 - $42,235	-356 Reduced 2.0%	17,468 $2.02 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $114,022 - $142,507	-1,328 Reduced 6.93%	17,824 $1.91 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $1,514 - $1,737	-20 Reduced 0.1%	19,152 $1.63 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $513,755 - $606,454	-6,923 Reduced 26.53%	19,172 $1.48 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $286,380 - $307,175	3,495 Added 15.46%	26,095 $2.2 Million
Q3 2017 Oct 30, 2017	BUY	$77.07 - $85.54 $1.74 Million - $1.93 Million	22,600	22,600 $1.93 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.

Account

Tocqueville Asset Management L.P. Eli Lilly & CO Transaction History